Shattuck Labs, Inc. STTK
5.47 USD +0.15 (+2.82%)
At closeNov 3, 2026, 4:01 PM EST
5.47 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
5.24 Day range 5.56
1.72 52-week range 8.33
- YTD
- +49.86%
- 1 year
- +174.87%
Held by funds
69 US ETFs and mutual funds hold STTK · largest positions
Ownership
Held by insiders 13.41%
Held by institutions 74.68%
Float held by institutions 86.24%
Institutions 109
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 15.00% | 7,159,090 | 7.87M | Sep 29, 2024 |
| Prosight Management, Lp | 11.90% | 5,678,726 | 6.25M | Sep 29, 2024 |
| Redmile Group, LLC | 11.76% | 5,615,489 | 6.18M | Sep 29, 2024 |
| Adage Capital Partners GP L.L.C. | 6.07% | 2,900,000 | 3.19M | Sep 29, 2024 |
| Blackrock Inc. | 5.47% | 2,613,294 | 2.87M | Sep 29, 2024 |
| Vanguard Group Inc | 5.03% | 2,401,909 | 2.64M | Sep 29, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.75% | 1,314,560 | 1.45M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.14% | 1,021,505 | 1.12M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.45% | 692,870 | 762.16K | Sep 29, 2024 |
| Fidelity Series Small Cap Opportunities Fund | 1.30% | 622,739 | 685.01K | Aug 30, 2024 |
| Franklin Strategic Series-Franklin Biotechnology Discove | 1.06% | 505,804 | 556.38K | Jul 30, 2024 |
| Fidelity Small Cap Index Fund | 0.84% | 401,775 | 441.95K | Aug 30, 2024 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROUS TYLER | Director | Purchase | Jun 27, 2024 | 238,088 |
| DEYOUNG CASI | Officer | Stock Award(Grant) | Jan 9, 2024 | 91,497 |
| NEILL ANDREW R. | Chief Financial Officer | Stock Award(Grant) | Jan 9, 2024 | 173,446 |
| PANDITE ARUNDATHY N. | Officer | Stock Award(Grant) | Jan 9, 2024 | 219,280 |
| REDMILE GROUP, L.L.C. | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 3, 2024 | 0 |
| SCHREIBER TAYLOR M.D., PH.D. | Chief Executive Officer | Purchase | Oct 6, 2024 | 2,681,750 |
